Genetic Intelligence - Genetic Intelligence Brief

Welcome to Larry Senour

We are excited to welcome Larry Senour to Genetic Intelligence to help lead business development. Larry has 30 years of healthcare experience in strategy, operations and transaction roles, including 23

VIDEO: Experience Genetic Intelligence

Watch the Genetic Intelligence vision. Genetic Intelligence finds truly causal disease targets and designs medicines to fix them. With Genetic Intelligence, you can step into the future of drug discovery.

Update

5,000 Alzheimer's disease WGS Access

Genetic Intelligence recently received access to ~5,000 whole genomes of well-characterized individuals with Alzheimer’s disease or other related dementias and controls. This data is from the NIAGADS data

Perspective

Shifting perspectives on our WGS and lower sample numbers focus

Increasingly, we are seeing the genetic field slowly pivot toward the path we at GI have insisted on (and blazed) all along. Namely, 1) whole genome (WGS) instead of whole exome (WES) and 2) well characterized cohorts (which can mean smaller number of samples) instead of larger and larger studies.

Getting Started

Welcome to the Genetic Intelligence Brief

It's great to have you here. The GI Brief is designed to be concise, accessible, and bearer of answers. Let's jump in.

Update

Genetic Intelligence awarded Competitive grant from the National Science Foundation

Genetic Intelligence has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $225,000 to conduct research and development (R&D) work on causal disease gene identification from Whole Genomes using Artificial Intelligence